Shareholder alert: pomerantz law firm investigates claims on behalf of investors of biodexa pharmaceuticals plc - bdrx

New york city, ny / accesswire / november 26, 2024 / pomerantz llp is investigating claims on behalf of investors of biodexa pharmaceuticals plc ("biodexa" or the "company") (nasdaq:bdrx). such investors are advised to contact danielle peyton at newaction@pomlaw.com or 646-581-9980, ext.
BDRX Ratings Summary
BDRX Quant Ranking